EP3844189
DOSING STRATEGY THAT MITIGATES CYTOKINE RELEASE SYNDROME FOR CD3/CD20 BISPECIFIC ANTIBODIES
:
EP einkaleyfi: Þýðing ekki lögð inn:
30.8.2019:
22.1.2025:
19782800.7
:
29.8.2039
:
DOSING STRATEGY THAT MITIGATES CYTOKINE RELEASE SYNDROME FOR CD3/CD20 BISPECIFIC ANTIBODIES
30.8.2019
22.1.2025
:
Regeneron Pharmaceuticals, Inc.:
777 Old Saw Mill River Road, Tarrytown, NY 10591, US
:
BROWNSTEIN, Carrie:
New York, New York 10023, US
:
LOWY, Israel:
Tarrytown, New York 10591, US
:
ADRIAENS, Lieve Lucille:
Tarrytown, New York 10591, US
:
201862726137 P:
31.8.2018:
US
:
201862774019 P:
30.11.2018:
US
:
201962861100 P:
13.6.2019:
US
:
US2019049027:
30.8.2019
:
C07K 16/28, A61K 31/573, A61K 39/00